Amniotic fluid alpha-fetoprotein testing in relative Japanese women

Prenatal Diagnosis

Volumn 19, Issue 8, 1999, Pages 761-763

  Onda, Takekazu ^a   Fukushima, Kazuo ^a   Tanaka, Tadao ^a   Sawa, Rintaro ^b   Hayashi, Zuisei ^b   Tsutsumi, Osamu ^c   Takai, Yasushi ^c   Yoshida, Koyo ^d   Nakamura, Yasushi ^d   Hoshi, Kazuhiko ^e   Fukada, Yukihito ^e   Okai, Takashi ^f   Sakai, Masato ^f   Kitagawa, Michihiro ^g   Akiyama, Yoshiaki ^g   Shimomura, Katsunori ^h   Myrick, Faye ⁱ   Dowman, A Christine ⁱ   Grier, Robert E ^i,j  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

^e UNIVERSITY OF YAMANASHI   (Japan)

^f Aiiku Maternal and Child Health Center   (Japan)

^g National Ohkura Hospital   (Japan)

^h Idenics Company   (Japan)

ⁱ Genzyme Genetics   (United States)

^j Genzyme Genetics   (United States)

more..

Author keywords

Amniotic fluid alpha fetoprotein; Japanese; Prenatal testing

Indexed keywords

ALPHA FETOPROTEIN;

AMNION FLUID ANALYSIS; ARTICLE; FEMALE; FETUS; HUMAN; JAPAN; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE;

ALPHA-FETOPROTEINS; AMNIOCENTESIS; AMNIOTIC FLUID; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GESTATIONAL AGE; HUMANS; JAPAN; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REFERENCE VALUES;

EID: 0032868751     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199908)19:8<761::AID-PD623>3.0.CO;2-I     Document Type: Article

References (11)

1. American College of Obstetrics and Gynecology (ACOG). 1996. Maternal serum screening. Educational Bulletin, Number 228. ACOG: Washington, DC.
2. Baumgarten A. 1986. Racial difference and biological significance of maternal serum-alpha-fetoprotein. Lancet i: 573.
3. Crandall BF, Hanson FW, Tennant F, Perdue ST. 1989. α-fetoprotein levels in amniotic fluid between 11 and 15 weeks. Am J Obstet Gynecol 160: 1204-1206.
4. Crandall BF, Lebherz TB, Schroth PC, Matsumoto M. 1983. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 29: 531-533.
5. Cuckle HS, Wald NJ. 1985. Amniotic fluid AFP levels and Down syndrome. Lancet i: 290-291.
6. Drugan A, Syner FN, Greb A, Evans MI. 1988. Amniotic fluid alpha-fetoprotein and acetylcholinesterase in early genetic amniocentesis. Obstet Gynecol 72: 35-38.
7. Elejalde BR, Elejalde MM, Acuna JM, Thelen D, Trujillo C, Karrmann M. 1990. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis. Am J Med Genet 35: 188-196.
8. Jorgensen FS, Sundberg K, Rasmussen AG, Arends J, Norgaard-Pedersen B. 1995. Alpha-fetoprotein and acetylcholinesterase activity in first- and early second-trimester amniotic fluid. Prenat Diagn 15: 621-625.
9. Macri JN, Weiss RR, Elligers KW, Federgreen WR. 1976. Racial differences in maternal serum-alpha-fetoprotein. Lancet i: 207-208.
10. Onda T, Kitagawa M, Takeda O, Sago H, Kubonoya K, Iinuma K, Bradley LA, Canick JA, Krasikov NE, Ponting NR, Grier RE. 1996. Triple marker screening in native Japanese women. Prenat Diagn 16: 713-717.
11. Shapiro LM, Skinner LG, Philips HV, Whitfield CR. 1975. Racial variations in maternal serum-alpha-fetoprotein. Lancet ii: 1142.